The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Common Variable Immunodeficiency

Common Variable Immunodeficiency

June 1, 2008 • By Daniel Myrtek, PhD, and Ulrich Salzer, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Common variable immunodeficiency (CVID) has been recognized as the most common symptomatic form of antibody deficiency diagnosed in adulthood since its first description by Janeway and colleagues.1 The clinical spectrum of CVID is heterogeneous, but this condition is usually characterized by hypogammaglobulinemia and recurrent bacterial infections. However, the phenotypic and immunologic variability of this disease still marks the diagnosis “CVID” as a grab bag for multiple diseases. Thus, the etiology of CVID is believed to be multifactorial and still holds many unanswered questions. Recent discoveries in the molecular genetics and immunologic basis of this disease have shed important new light on its pathogenesis and raised prospects for earlier and better diagnosis and treatment.

You Might Also Like
  • When Immunodeficiency & Autoimmunity Coexist
  • When Immunodeficiency & Autoimmunity Coexist
  • How to Watch for Immune Deficiencies & Manage Risk
Explore This Issue
June 2008

CVID affects both genders equally, with an incidence estimated at 1 in 10,000 to 1 in 50,000.2 In a small number of patients, the onset of disease may occur in childhood, but the mean age of onset for the majority of patients is about 23 for men and 28 for women. There is a significant delay—four to six years on average—between the median age of symptom onset and the age at diagnosis.3

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Clinical Features

Although the clinical phenotype of CVID may be heterogeneous, one key characteristic of this disease is an impaired ability to produce antibodies. This disturbance manifests in decreased levels of immunoglobulin (Ig) G, IgA, and, sometimes, IgM isotypes and in an impaired or even absent antibody response upon antigenic challenge. This results in a failure to respond to vaccinations and an increased susceptibility to infections. Infections are usually localized in the respiratory tract and a majority of patients have recurrent bronchitis, sinusitis, or otitis (which is more common in childhood-onset CVID), and have had one or more episodes of pneumonia.

TABLE 1: Differential Diagnosis of Hypogammaglobulinemia
click for large version
TABLE 1: Differential Diagnosis of Hypogammaglobulinemia

Typical pathogens affecting patients with CVID are encapsulated bacteria like Haemophilus influenzae, Streptococcus pneumoniae, or Moraxella catharralis. A significant number of CVID patients also suffer from gastrointestinal tract infections caused by Giardia lamblia, Campylobacter, or Salmonella species. Pulmonary symptoms of CVID may be accompanied by an obstructive lung phenotype (e.g., chronic bronchitis) and asthma. The lung represents the Achilles’ heel of the CVID patient and chronic lung damage (e.g., bronchiectasis, lung fibrosis, and emphysema) is one of the most common causes of morbidity and mortality in the CVID cohort.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The respiratory system of CVID patients may also be affected by granulomatous inflammation, characterized by sarcoid-like lesions in lymph nodes and other histology specimens. This accompanying disease is found in approximately 10% to 22% of CVID patients. In addition to the lung, virtually any other organ system can be affected, but the involvement of lung and liver in particular worsens the patient’s prognosis and is often difficult to treat. High-resolution computer tomography is the method of choice to evaluate and monitor the status and progression of lung-related pathology in CVID patients.

Pages: 1 2 3 4 5 6 7 | Single Page

Filed Under: Conditions Tagged With: Common variable immunodeficiency, Diagnostic Criteria, genetics, hypogammaglobulinemia, Infection, Pathogenesis, TreatmentIssue: June 2008

You Might Also Like:
  • When Immunodeficiency & Autoimmunity Coexist
  • When Immunodeficiency & Autoimmunity Coexist
  • How to Watch for Immune Deficiencies & Manage Risk
  • ADA2 Mutation Connects Vascular Pathology to Immunodeficiency

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)